Daedalus’ executives have over one hundred combined years of biopharma experience. They are supported by the work of dozens of leading researchers, clinicians, and executives giving Daedalus’ clients a formidable advantage in an increasingly competitive orphan environment.

Bruce G. O’Brien, BA -- Managing Partner. Duke University.

Tatyana Khavinson, MS – Partner. Database and IT Design. St. Petersburg Institute of Technology (Russia).

John C. Rodney, JD -- Legal Counsel. Duke University. Dickinson School of Law. Partner. Clark Hill.

Eugene H. Koziara, MD -- Clinical Advisor. University of Michigan.

Michael Stevens, PharmD -- bioXcross Advisor. Purdue University.